Cargando…
Risk of mortality in COVID-19 patients with newly diagnosed and pre-existing diabetes
Autor principal: | Sathish, Thirunavukkarasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Primary Care Diabetes Europe. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695123/ https://www.ncbi.nlm.nih.gov/pubmed/34974995 http://dx.doi.org/10.1016/j.pcd.2021.12.002 |
Ejemplares similares
-
Newly diagnosed diabetes in COVID-19 patients
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021) -
Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021) -
Newly diagnosed diabetes in patients with mild to moderate COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021) -
Persistence of new-onset diabetes in the post-acute phase of COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2022) -
Comment on “Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus”
por: Wu, Yutong, et al.
Publicado: (2020)